KEEL vs. VOR
KEEL (Keel Infrastructure Corporation) and VOR (Vor Biopharma Inc.) are both stocks. KEEL operates in Capital Markets (Financial Services), while VOR operates in Biotechnology (Healthcare). Over the past 5 years, KEEL returned 5.07%/yr vs -49.81%/yr for VOR. At a 0.20 correlation, their price movements are largely independent.
Performance
KEEL vs. VOR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KEEL achieves a 140.85% return, which is significantly higher than VOR's 1.61% return.
KEEL
- 1D
- 10.33%
- 1M
- 42.57%
- YTD
- 140.85%
- 6M
- 94.50%
- 1Y
- 530.92%
- 3Y*
- 73.17%
- 5Y*
- 5.07%
- 10Y*
- —
VOR
- 1D
- 0.99%
- 1M
- -21.55%
- YTD
- 1.61%
- 6M
- 58.97%
- 1Y
- 196.92%
- 3Y*
- -48.97%
- 5Y*
- -49.81%
- 10Y*
- —
KEEL vs. VOR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
KEEL Keel Infrastructure Corporation | 140.85% | 57.72% | -48.80% | 561.36% | -91.29% | 68.90% |
VOR Vor Biopharma Inc. | 1.61% | -41.08% | -50.67% | -66.17% | -42.77% | -69.01% |
Correlation
The correlation between KEEL and VOR is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Feb 8, 2021 | 0.20 |
The correlation between KEEL and VOR shifts across timeframes, from 0.10 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.
Fundamentals
KEEL:
$3.12B
VOR:
$571.62M
KEEL:
-$0.51
VOR:
-$53.66
KEEL:
$229.28M
VOR:
$0.00
KEEL:
-$18.90M
VOR:
-$23.00K
KEEL:
-$149.60M
VOR:
-$1.13B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KEEL vs. VOR — Risk / Return Rank
KEEL
VOR
KEEL vs. VOR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Keel Infrastructure Corporation (KEEL) and Vor Biopharma Inc. (VOR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| KEEL | VOR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.70 | ||
| Sortino ratioReturn per unit of downside risk | +1.08 | ||
| Omega ratioGain probability vs. loss probability | 1.47 | 1.35 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 7.27 | 2.27 | +5.00 |
| Martin ratioReturn relative to average drawdown | 12.09 | 3.30 | +8.79 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| KEEL | VOR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 4.85 | 1.15 | +3.70 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.05 | -0.43 | +0.48 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.07 | -0.46 | +0.52 |
Drawdowns
KEEL vs. VOR - Drawdown Comparison
The maximum KEEL drawdown since its inception was -95.72%, roughly equal to the maximum VOR drawdown of -99.72%. Use the drawdown chart below to compare losses from any high point for KEEL and VOR.
Loading charts...
Drawdown Indicators
| KEEL | VOR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.72% | -99.72% | +4.00% |
Max Drawdown (1Y)Largest decline over 1 year | -73.65% | -87.15% | +13.50% |
Max Drawdown (3Y)Largest decline over 3 years | -81.04% | -97.07% | +16.03% |
Max Drawdown (5Y)Largest decline over 5 years | -95.72% | -99.32% | +3.60% |
Current DrawdownCurrent decline from peak | -36.19% | -98.77% | +62.58% |
Average DrawdownAverage peak-to-trough decline | -67.60% | -88.72% | +21.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.21% | 60.00% | -15.79% |
Volatility
KEEL vs. VOR - Volatility Comparison
Keel Infrastructure Corporation (KEEL) has a higher volatility of 28.39% compared to Vor Biopharma Inc. (VOR) at 22.75%. This indicates that KEEL's price experiences larger fluctuations and is considered to be riskier than VOR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KEEL | VOR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.39% | 22.75% | +5.64% |
Volatility (6M)Calculated over the trailing 6-month period | 70.46% | 72.58% | -2.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 110.59% | 171.96% | -61.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 105.02% | 116.47% | -11.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 291.45% | 116.80% | +174.65% |
Dividends
KEEL vs. VOR - Dividend Comparison
Neither KEEL nor VOR has paid dividends to shareholders.
Financials
KEEL vs. VOR - Financials Comparison
This section allows you to compare key financial metrics between Keel Infrastructure Corporation and Vor Biopharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
KEEL and VOR have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KEEL has higher volatility (28.39%) compared to VOR (22.75%). In terms of maximum drawdown, KEEL dropped -95.72% vs VOR's -99.72%.
KEEL currently has the higher Sharpe Ratio (4.85 vs 1.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KEEL and VOR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer